title: Safety and management of new primary melanomas during receipt of BRAF inhibitors.
authors.affiliation: Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon; and University Claude Bernard Lyon 1, Lyon, France.
authors.forename: Marie
authors.initials: M
authors.lastname: Perier-Muzet
authors.affiliation: Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon; University Claude Bernard Lyon 1; and Cancer Research Center of Lyon, Lyon, France.
authors.forename: Luc
authors.initials: L
authors.lastname: Thomas
authors.affiliation: Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon; and University Claude Bernard Lyon 1, Lyon, France stephane.dalle@chu-lyon.fr.
authors.forename: Stéphane
authors.initials: S
authors.lastname: Dalle
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008545:Melanoma / Q000453:epidemiology*; D016609:Neoplasms, Second Primary / Q000453:epidemiology*; D012878:Skin Neoplasms / Q000453:epidemiology*